Financials Inari Medical, Inc.

Equities

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 12/07/2024 BST 5-day change 1st Jan Change
54.41 USD +2.22% Intraday chart for Inari Medical, Inc. +5.88% -16.19%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,252 4,582 3,410 3,739 3,163 - -
Enterprise Value (EV) 1 4,088 4,406 3,084 3,623 3,082 3,048 3,062
P/E ratio 323 x 507 x -116 x -2,164 x -59.5 x 384 x 112 x
Yield - - - - - - -
Capitalization / Revenue 30.4 x 16.5 x 8.89 x 7.57 x 5.28 x 4.48 x 3.82 x
EV / Revenue 29.3 x 15.9 x 8.04 x 7.34 x 5.15 x 4.32 x 3.7 x
EV / EBITDA 206 x 288 x -147 x 433 x -133 x 122 x 46.9 x
EV / FCF -76.4 x 372 x -129 x 116 x -593 x 206 x 74.9 x
FCF Yield -1.31% 0.27% -0.78% 0.86% -0.17% 0.49% 1.34%
Price to Book 21.5 x 19.2 x 8.23 x 7.93 x 7.5 x 7.27 x 6.64 x
Nbr of stocks (in thousands) 48,711 50,205 53,653 57,590 58,138 - -
Reference price 2 87.29 91.27 63.56 64.92 54.41 54.41 54.41
Announcement Date 09/03/21 23/02/22 27/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 51.13 139.7 277 383.5 493.6 598.7 706.5 827.3
EBITDA 1 - 19.8 15.3 -20.98 8.364 -23.24 24.97 65.36
EBIT 1 - 18.42 10.84 -28.1 -2.371 -42.38 4.881 36.26
Operating Margin - 13.19% 3.92% -7.33% -0.48% -7.08% 0.69% 4.38%
Earnings before Tax (EBT) 1 - 13.79 10.68 -26.18 4.246 -44.05 7.326 35.52
Net income 1 - 13.79 9.84 -29.27 -1.636 -49.84 8.215 28.58
Net margin - 9.87% 3.55% -7.63% -0.33% -8.32% 1.16% 3.45%
EPS 2 -0.1400 0.2700 0.1800 -0.5500 -0.0300 -0.9143 0.1417 0.4860
Free Cash Flow 1 - -53.52 11.84 -23.92 31.22 -5.2 14.8 40.9
FCF margin - -38.32% 4.27% -6.24% 6.32% -0.87% 2.09% 4.94%
FCF Conversion (EBITDA) - - 77.42% - 373.23% - 59.26% 62.58%
FCF Conversion (Net income) - - 120.34% - - - 180.17% 143.11%
Dividend per Share 2 - - - - - - - -
Announcement Date 21/02/20 09/03/21 23/02/22 27/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 83.22 86.75 92.74 96.2 107.8 116.2 119 126.4 132.1 143.2 143.8 151.5 160.2 168.2 170.6
EBITDA 1 3.444 -1.983 -8.095 -8.018 -4.001 -2.365 0.63 4.285 3.131 -12.56 -9.878 -4.707 -0.2325 2.86 7.329
EBIT 1 1.746 -3.082 -9.328 -9.798 -5.891 -5.338 -1.51 2.113 -0.319 -17.18 -14.95 -10.14 -6.698 -2.73 0.3203
Operating Margin 2.1% -3.55% -10.06% -10.18% -5.47% -4.6% -1.27% 1.67% -0.24% -12% -10.4% -6.69% -4.18% -1.62% 0.19%
Earnings before Tax (EBT) 1 1.681 -3.129 -8.935 -9.313 -4.808 -1.194 3.024 5.59 -3.176 -16.09 -15.04 -9.695 -5.123 -2.014 1.384
Net income 1 1.107 -3.129 -10.19 -10.15 -5.798 -2.218 2.085 3.162 -4.667 -24.2 -14.35 -9.829 -5.943 -1.936 0.9287
Net margin 1.33% -3.61% -10.98% -10.55% -5.38% -1.91% 1.75% 2.5% -3.53% -16.9% -9.98% -6.49% -3.71% -1.15% 0.54%
EPS 2 0.0200 -0.0600 -0.1900 -0.1900 -0.1100 -0.0400 0.0400 0.0500 -0.0800 -0.4200 -0.2629 -0.1800 -0.1086 -0.0280 0.0150
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 23/02/22 04/05/22 03/08/22 02/11/22 27/02/23 03/05/23 02/08/23 01/11/23 28/02/24 30/04/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - 164 176 326 115 80.8 115 101
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -53.5 11.8 -23.9 31.2 -5.2 14.8 40.9
ROE (net income / shareholders' equity) - 17.1% 4.48% -8.92% 2.27% -4.7% 3.59% 9.55%
ROA (Net income/ Total Assets) - - - - 1.7% - - -
Assets 1 - - - - -96.15 - - -
Book Value Per Share 2 - 4.070 4.750 7.720 8.190 7.250 7.480 8.200
Cash Flow per Share 2 - 0.0400 - -0.2600 0.6300 0.7100 -0.1000 -
Capex 1 - 5.46 - 9.95 4.71 7.7 8.8 10.7
Capex / Sales - 3.91% - 2.59% 0.95% 1.29% 1.25% 1.29%
Announcement Date 21/02/20 09/03/21 23/02/22 27/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
54.41 USD
Average target price
64.09 USD
Spread / Average Target
+17.79%
Consensus
  1. Stock Market
  2. Equities
  3. NARI Stock
  4. Financials Inari Medical, Inc.